Medical Director, Vertex Pharmaceuticals Inc.
Pediatric Pulmonology
Dr. Samuel M. Moskowitz, MD
|
|
Give Review
Samuel Moskowitz works in the field of Pediatric Pulmonology. He studied medicine at Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. Samuel M. Moskowitz is a published physician. He has 34 publications published. The most current publication "Molecular analysis of Hurler syndrome in Druze and Muslim Arab patients in Israel: multiple allelic mutations of the IDUA gene in a small geographic area." He accepts Medicare.
Publications
- Site-specific activity of the acyltransferases HtrB1 and HtrB2 in Pseudomonas aeruginosa lipid A biosynthesis.
- Nitrite modulates bacterial antibiotic susceptibility and biofilm formation in association with airway epithelial cells.
- Enhanced In Vitro Formation and Antibiotic Resistance of Nonattached Pseudomonas aeruginosa Aggregates through Incorporation of Neutrophil Products.
- Azithromycin May Antagonize Inhaled Tobramycin when Targeting Pseudomonas aeruginosa in Cystic Fibrosis.
- A divergent Pseudomonas aeruginosa palmitoyltransferase essential for Cystic fibrosis-specific lipid A.
- Polymyxin resistance of Pseudomonas phoQ mutants is dependent on additional two-component regulatory systems.
- Effects of azithromycin in Pseudomonas aeruginosa burn wound infection.
- PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated Cystic fibrosis patients.
- PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated Cystic fibrosis patients.
- Randomized trial of biofilm testing to select antibiotics for Cystic fibrosis airway infection.
- Neutrophil Extracellular Trap (NET)-Mediated Killing of Pseudomonas aeruginosa: Evidence of Acquired Resistance within the CF Airway, Independent of CFTR.
- Mechanisms of bacterial virulence in pulmonary infections.
- Clinical practice and genetic counseling for Cystic fibrosis and CFTR-related disorders.
- Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with Cystic fibrosis.
- Genetic adaptation by Pseudomonas aeruginosa to the airways of Cystic fibrosis patients.
- The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the Cystic fibrosis airway.
- Pandoraea bacteremia in a Cystic fibrosis patient with associated systemic illness.
- Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with Cystic fibrosis.
- PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A.
- A study of low dose peginterferon alpha-2b with ribavirin for the initial treatment of chronic hepatitis C.
- Juvenile GM2 gangliosidosis caused by substitution of histidine for arginine at position 499 or 504 of the alpha-subunit of beta-hexosaminidase.
- Molecular analysis of Hurler syndrome in Druze and Muslim Arab patients in Israel: multiple allelic mutations of the IDUA gene in a small geographic area.
- Mutation in Scheie syndrome (MPS IS): a G-->A transition creates new splice site in intron 5 of one IDUA allele.
- Cloning and characterization of cDNA encoding canine alpha-L-iduronidase. mRNA deficiency in mucopolysaccharidosis I dog.
- Genetic adaptation of Pseudomonas aeruginosa to the airways of Cystic fibrosis patients is catalyzed by hypermutation.
- Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for Cystic fibrosis airway infection.
- Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment.
- Pseudomonas aeruginosa lipid A diversity and its recognition by Toll-like receptor 4.
- Shifting patterns of inhaled antibiotic use in Cystic fibrosis.
- Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish Cystic fibrosis patients.
- Pseudomonas aeruginosa Type III secretion system interacts with phagocytes to modulate systemic infection of zebrafish embryos.
- The role of Pseudomonas lipopolysaccharide in Cystic fibrosis airway infection.
- Colistin susceptibility testing: evaluation of reliability for Cystic fibrosis isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia.
Schools
Harvard Medical School
Chldrns Hospital and Regl Mc
University WashAff Hosps
Conditions Treated
- Cystic Fibrosis
Doctors Specialties
- Pediatric Pulmonology
Accepted Insurances
Education
-
University of Washington -
Harvard Medical School
Hospital
-
Massachusetts General Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Benjamin A. Nelson, MD |
|
|
Dr. Anna T. Labowsky, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary A. Visner, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert H. Lim, MD |
|
|
Dr. Jane E. Gross, MD |
|
|
Dr. Jonathan M. Gaffin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Umakanth A. Khatwa, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karissa A. Brazauskas, MD |
|
|
Dr. Levent Midyat, MD |
|
|
Dr. Michelle K. Trivedi, MD |
|
|
Dr. Debra M. Boyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Virginia S. Kharasch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ahmet Uluer, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine A. Sheils, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas R. Martin II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Demet Toprak, MD |